BENIGN PROSTATIC HYPERTROPHY: ETIOLOGY, PATHOGENESIS AND THERAPEUTIC CONSEQUENCES
Prof. Aksam Yassin, Dept. of Urology & Human Sexuality, Buckhoerner Moor 110, Norderstedt,
Germany. Due to the higher life and health expectancy in modern
societies, the quality of life (QoL) became a very important issue in benign prostatic
hyperplasia or syndrome (BPH or BPS) Population. It is one of the major concepts identified
by patients to be important in relation to sexuality before and after BPH therapy.
Experts expect a drastically higher increase of elderly population within the
next two decades We obviously identify -according to the 12 known studies
and to our experience in terms of BPH and sexuality- a higher correlation between
clinically manifested BPH and erectile/ ejaculatory disorders (ALF ONE & MSAM-7
studies
). These studies have more a demographic and statistical characters
regarding to this concern. We were more concerned in our research group to
study the impact on sexuality in
this population not only as the result
of impaired QoL due to voiding disturbances or nocturia (tiredness, lack of sleep
etc
) but also to look for the reasons in the Microanatomy and Histo-chemistry. The hormonal imbalance (aging related Lack of Testosterone
and DHT) can give a chance for Aging Changes in the whole male
organism including the tissues of Prostate and Corpus cavernosum stromas. The
connective collagen stroma will increase, enhancing the compartments of Alpha-1
Adrenocepros 1 & 2. Figure
2:
 Furthermore the impact on sexuality resulting from the
various treatment modalities of BPH, either medical, surgical or instrumental
has been often neglected in the past and not sufficiently investigated. We also
try in this presentation to update the influence on sexual function of current
treatments for the symptomatic BPH. Professor Aksam Yassin MD PhD
EdD FEBU Professor of Urology & Human Sexuality Buckhoerner Moor 110 22846 Norderstedt, Hamburg, Germany Degrees: BBMSc. - Bachelor of Basic Medical Sciences, University of Damascus, 1977 MD - Doctor of Medicine, Univ. of Damascus, 1980 FAU - Facharzt fur Urologie (specialist in urology), Hanover, 1986 Ed.D - Doctor of Education, University of Sarasota, Florida/USA, June
1996 Ph.D - Medical Sciences, Hamburg University, September 18th
\ 1998 Clinical Posts: Consultant Uro-Surgeon, clinic for urology, andrology
and venereal diseases, Hamburg/Germany,
since 1987 - affiliated
with the urologic academic dept. At Hamburg
University for BPH and T1/T2 prostate cancer research. Professor
of Urology, Zurich University/Switzerland, November 1993 Head of the European Information Office
of the University of Sarasota in Hamburg/Germany, since 1994 Adjunct Professor, Education and Behavioural Sciences at
the University of Sarasota, Florida/USA (teaching program for medical sociology and sexual medicine), since August 1995 Professor
of Urology at the Gulf Medical College Ajman / UAE since 2,000. |